Skip to main content

Agilent Technologies, Millipore, AnaSpec, Tripos

Premium
Agilent Technologies last week launched its EZChrom Elite 3.2 software for use with HPLC data. In addition to compatibility with Agilent’s 1200 Series liquid chromatographers, the software works with all makes of LCs, an Agilent spokesman said.
 
The 3.2 version features a new navigation pane for easy access to software functions and analysis tools that allow users to specify custom identifiers and analysis parameters on a peak-by-peak or injection basis directly in the sequence table, the company said.
 

 
Millipore launched this week the first round of adenoviral shRNA expression vector reagents targeting the human druggable genome. The classes included in this release represent all the major protein classes amenable to small-molecule intervention, the company said in a statement. That includes kinases, GPCRs, and secreted proteins.
 
The AdenoSilence vectors are available in three different sequence variants sold separately or as a kit. The vectors “allow for single-step delivery of shRNA through the direct application of the virus supernatants onto a primary cell culture, thereby making any additional transfection reagents or complex transfection protocols unnecessary,” Millipore said.
 

 
AnaSpec released three protein phosphatase assay kits this week. The fluorimetric EnzoLyte FDP assay kit is optimized for assaying protein phosphatases requiring a pH of at least 6.5 for optimal activity, the company said in a statement. Its EnzoLyte MFP assay kit, also a fluorimetric assay, is for phosphatases that require a pH of no more than 6.5. AnaSpec’s colorimetric kit, the EnzoLyte pNPP assay kit, utilizes p-nitrophenyl phosphate as a substrate and shows high sensitivity and a wide linear range. The detection limit is generally 3 ng or lower.
 

 
Tripos this week launched the Advanced Protein Modeling software package combining homolog identification, sequence alignment, and interactive comparative protein structure modeling. APM is available as an optional component of Tripos’ SYBYL 7.3 product line and is based on the FUGUE and ORCHESTRAR technologies.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.